494 related articles for article (PubMed ID: 16126224)
1. Study of a major intermediate in the oxidative folding of leech carboxypeptidase inhibitor: contribution of the fourth disulfide bond.
Arolas JL; Popowicz GM; Bronsoms S; Aviles FX; Huber R; Holak TA; Ventura S
J Mol Biol; 2005 Sep; 352(4):961-75. PubMed ID: 16126224
[TBL] [Abstract][Full Text] [Related]
2. Designing out disulfide bonds of leech carboxypeptidase inhibitor: implications for its folding, stability and function.
Arolas JL; Castillo V; Bronsoms S; Aviles FX; Ventura S
J Mol Biol; 2009 Sep; 392(2):529-46. PubMed ID: 19559710
[TBL] [Abstract][Full Text] [Related]
3. Major kinetic traps for the oxidative folding of leech carboxypeptidase inhibitor.
Salamanca S; Li L; Vendrell J; Aviles FX; Chang JY
Biochemistry; 2003 Jun; 42(22):6754-61. PubMed ID: 12779330
[TBL] [Abstract][Full Text] [Related]
4. NMR structural analysis of an analog of an intermediate formed in the rate-determining step of one pathway in the oxidative folding of bovine pancreatic ribonuclease A: automated analysis of 1H, 13C, and 15N resonance assignments for wild-type and [C65S, C72S] mutant forms.
Shimotakahara S; Rios CB; Laity JH; Zimmerman DE; Scheraga HA; Montelione GT
Biochemistry; 1997 Jun; 36(23):6915-29. PubMed ID: 9188686
[TBL] [Abstract][Full Text] [Related]
5. NMR structural characterization and computational predictions of the major intermediate in oxidative folding of leech carboxypeptidase inhibitor.
Arolas JL; D'Silva L; Popowicz GM; Aviles FX; Holak TA; Ventura S
Structure; 2005 Aug; 13(8):1193-202. PubMed ID: 16084391
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of hydrogen bonding residues in the BPTI folding pathway.
Bulaj G; Goldenberg DP
J Mol Biol; 2001 Oct; 313(3):639-56. PubMed ID: 11676545
[TBL] [Abstract][Full Text] [Related]
7. Structure of a novel leech carboxypeptidase inhibitor determined free in solution and in complex with human carboxypeptidase A2.
Reverter D; Fernández-Catalán C; Baumgartner R; Pfänder R; Huber R; Bode W; Vendrell J; Holak TA; Avilés FX
Nat Struct Biol; 2000 Apr; 7(4):322-8. PubMed ID: 10742178
[TBL] [Abstract][Full Text] [Related]
8. Correlation between disulfide reduction and conformational unfolding in bovine pancreatic trypsin inhibitor.
Ma LC; Anderson S
Biochemistry; 1997 Mar; 36(12):3728-36. PubMed ID: 9132026
[TBL] [Abstract][Full Text] [Related]
9. Kinetic folding pathway of a three-disulfide mutant of bovine pancreatic ribonuclease A missing the [40-95] disulfide bond.
Xu X; Scheraga HA
Biochemistry; 1998 May; 37(20):7561-71. PubMed ID: 9585571
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the underlying cause of diversity of the disulfide folding pathway.
Chang JY
Biochemistry; 2004 Apr; 43(15):4522-9. PubMed ID: 15078098
[TBL] [Abstract][Full Text] [Related]
11. Disulfide formation and stability of a cysteine-rich repeat protein from Helicobacter pylori.
Devi VS; Sprecher CB; Hunziker P; Mittl PR; Bosshard HR; Jelesarov I
Biochemistry; 2006 Feb; 45(6):1599-607. PubMed ID: 16460007
[TBL] [Abstract][Full Text] [Related]
12. Pathway of oxidative folding of secretory leucocyte protease inhibitor: an 8-disulfide protein exhibits a unique mechanism of folding.
Lin CC; Chang JY
Biochemistry; 2006 May; 45(19):6231-40. PubMed ID: 16681396
[TBL] [Abstract][Full Text] [Related]
13. Cooperative folding of the isolated alpha-helical domain of hen egg-white lysozyme.
Bai P; Peng Z
J Mol Biol; 2001 Nov; 314(2):321-9. PubMed ID: 11718563
[TBL] [Abstract][Full Text] [Related]
14. Role of kinetic intermediates in the folding of leech carboxypeptidase inhibitor.
Arolas JL; Bronsoms S; Lorenzo J; Aviles FX; Chang JY; Ventura S
J Biol Chem; 2004 Sep; 279(36):37261-70. PubMed ID: 15226306
[TBL] [Abstract][Full Text] [Related]
15. Pathway of oxidative folding of bovine alpha-interferon: predominance of native disulfide-bonded folding intermediates.
Lin CC; Chang JY
Biochemistry; 2007 Mar; 46(12):3925-32. PubMed ID: 17328561
[TBL] [Abstract][Full Text] [Related]
16. Impact of an easily reducible disulfide bond on the oxidative folding rate of multi-disulfide-containing proteins.
Leung HJ; Xu G; Narayan M; Scheraga HA
J Pept Res; 2005 Jan; 65(1):47-54. PubMed ID: 15686534
[TBL] [Abstract][Full Text] [Related]
17. Regeneration of three-disulfide mutants of bovine pancreatic ribonuclease A missing the 65-72 disulfide bond: characterization of a minor folding pathway of ribonuclease A and kinetic roles of Cys65 and Cys72.
Iwaoka M; Juminaga D; Scheraga HA
Biochemistry; 1998 Mar; 37(13):4490-501. PubMed ID: 9521769
[TBL] [Abstract][Full Text] [Related]
18. Competition between DsbA-mediated oxidation and conformational folding of RTEM1 beta-lactamase.
Frech C; Wunderlich M; Glockshuber R; Schmid FX
Biochemistry; 1996 Sep; 35(35):11386-95. PubMed ID: 8784194
[TBL] [Abstract][Full Text] [Related]
19. Synthetic model proteins: contribution of hydrophobic residues and disulfide bonds to protein stability.
Hodges RS; Zhou NE; Kay CM; Semchuk PD
Pept Res; 1990; 3(3):123-37. PubMed ID: 2134057
[TBL] [Abstract][Full Text] [Related]
20. Structural characterization of an analog of the major rate-determining disulfide folding intermediate of bovine pancreatic ribonuclease A.
Laity JH; Lester CC; Shimotakahara S; Zimmerman DE; Montelione GT; Scheraga HA
Biochemistry; 1997 Oct; 36(42):12683-99. PubMed ID: 9335525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
